Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Apremilast may help treat hair loss in alopecia areata.

Baricitinib works better than methotrexate for severe alopecia areata.

Boosting certain cell signals can prevent hair loss from cancer treatments.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The new drug delivery system improves vitiligo treatment by enhancing melanocyte activity and viability.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Baricitinib helps regrow hair in teens with severe alopecia areata.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

Targeted photodynamic therapy is a promising method for precise disease treatment and diagnosis.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

New cancer treatments aim to reduce side effects and improve effectiveness.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.